42 completed, 23 terminated, 14 unknown, 6 recruiting. 92 Phase 3, 22 Phase 2.
Follow Lung Injury: new trials by email Literature Review of Lung Injury trials Research Report on Lung Injury
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ondansetron for the Prevention of Patient Self-Inflicted Lung Injury in Patients With ARDS - Pilot RCT Ondansetron hydrochloride 8 mg IV Q8H, 0.9 % Normal Saline 10 ml - ARDS (Acute Respiratory Distress Syndrome), Invasive Mechanical Ventilation | Phase 2 / Phase 3 | Not yet recruiting | Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal | 76 | 2026-10-01 | 2026-05-14 |
| Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging [18F]FAPI-74, 18F-FAPI-74 PET/CT Imaging - Allogeneic Stem Cell Transplantation, Lung Allograft Transplantation | Phase 3 | Recruiting | National Heart, Lung, and Blood Institute (NHLBI) | 210 | 2026-09-18 | 2026-10-26 |
| RECOMMEND Platform Trial Liberal RBC Transfusion, Restrictive RBC Transfusion - Extracorporeal Membrane Oxygenation Complication, ARDS (Acute Respiratory Distress Syndrome) | Phase 3 | Recruiting | Australian and New Zealand Intensive Care Research Centre | 600 | 2026-03-23 | 2026-05-13 |
| Dexamethasone Regimens for BPD Prevention in Preterm Infants Dexamethasone. Dart, Dexametasone. Medium - Infant, Premature, Bronchopulmonary Dysplasia (BPD) | Phase 3 | Not yet recruiting | The Children's Hospital of Zhejiang University School of Medicine | 970 | 2026-02-01 | 2025-11-24 |
| A Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota Transplantation Placebo control group, Human-derived active intestinal bacterial liquid group - Acute Respiratory Distress Syndrome (ARDS), Acute Lung Injury(ALI) | Phase 2 / Phase 3 | Recruiting | Shanghai University of Traditional Chinese Medicine | 60 | 2025-12-10 | 2026-01-15 |
| Efficacy of Nebulised Inhalational Steroids in Neonates With Meconium Aspiration Syndrome Budesonide, Normal Saline - Meconium Aspiration Syndrome | Phase 3 | Completed | Khyber Teaching Hospital | 60 | 2025-11-28 | 2026-08-13 |
| Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developing Bronchopulmonary Dysplasia (BPD) Air-sham, Zelpultide alfa - Bronchopulmonary Dysplasia | Phase 2 / Phase 3 | Recruiting | Airway Therapeutics, Inc. | 366 | 2025-02-03 | 2026-11-17 |
| Enhancing Lung Health in Kids With Structural Lung Damage and Malformations: Azithromycin (AZI) for Airway Infection Prevention Azithromycin 40 MG/ML, Placebo - Tracheomalacia, Bronchopulmonary Dysplasia (BPD) | Phase 3 | Not yet recruiting | Copenhagen University Hospital, Rigshospitalet | 150 | 2024-09-01 | 2024-05-14 |
| Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress Caffeine citrate, Placebo - Prematurity, Respiratory Disease | Phase 2 / Phase 3 | Recruiting | Ministry of Health, Saudi Arabia | 134 | 2023-10-12 | 2025-06-27 |
| Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy radiotherapy, Platinum-Based Drug, Immunotherapy - Non-small Cell Lung Cancer Stage III | Phase 3 | Unknown | Zhejiang Cancer Hospital | 105 | 2023-09-15 | 2023-09-13 |
| Nebulized Heparin for Prevention of Acute Lung Injury in Smoke Inhalation Injury Heparin, Normal Saline - Smoke Inhalation Injury, Acute Lung Injury | Phase 3 | Completed | Ain Shams University | 88 | 2023-06-01 | 2024-12-12 |
| Individualized Positive End-expiratory Pressure Guided by End-expiratory Lung Volume in the Acute Respiratory Distress Syndrome Invasive Mechanical ventilation, Neuromuscular Blocking Agents, Prone positioning - Respiratory Distress Syndrome, Adult | Phase 3 | Terminated | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 18 | 2022-11-01 | 2025-09-30 |
| Effect of Caffeine Versus Probiotic on Preterm Neonates With Bronchopulmonary Dysplasia Caffeine, Probiotic Formula - Bronchopulmonary Dysplasia | Phase 3 | Unknown | Tanta University | 90 | 2022-06-30 | 2023-01-12 |
| Efficacy and Safety of Pirfenidone Capsules in the Treatment of Pneumoconiosis Pirfenidone Capsules, placebo capsules - Pneumoconiosis | Phase 3 | Recruiting | Beijing Continent Pharmaceutical Co, Ltd. | 272 | 2022-06-07 | 2025-11-24 |
| Inhaled ZYESAMI (Aviptadil Acetate) for Treatment of Severe COVID-19 ZYESAMI™ (aviptadil acetate), Placebo, Nebulized administration of ZYESAMI™ or Placebo - SARS-CoV 2, COVID | Phase 3 | Withdrawn | APR Applied Pharma Research s.a. | 2021-12-15 | 2026-05-14 | |
| Intratracheal Budesonide With Surfactant to Prevent Bronchopulmmonary Dysplasia. Poractant Alfa Intratracheal Suspension [Curosurf], Budesonide 0.5 MG/ML - Bronchopulmonary Dysplasia, Respiratory Distress Syndrome in Premature Infant | Phase 3 | Unknown | Hospital Clinic of Barcelona | 50 | 2021-10-01 | 2021-09-13 |
| Effect of Autologous Cord Blood Mononuclear Cells for Treatment of Bronchopulmonary Dysplasia in Extremely Preterm Neonates autologous cord blood mononuclear cells - BPD | Phase 3 | Unknown | Guangdong Women and Children Hospital | 76 | 2021-10-01 | 2021-10-08 |
| The Budesonide in Babies (BiB) Trial budesonide (Pulmicort nebulizing suspension)., surfactant (poractant alfa;Curosurf) - Bronchopulmonary Dysplasia (BPD), Respiratory Distress Syndrome | Phase 3 | Active not recruiting | NICHD Neonatal Research Network | 642 | 2021-04-01 | 2026-04-15 |
| Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19 ZYESAMI™ (aviptadil acetate), Placebo, Nebulized administration of ZYESAMI™ or Placebo - SARS-CoV 2, COVID | Phase 2 / Phase 3 | Terminated | APR Applied Pharma Research s.a. | 144 | 2021-02-15 | 2023-02-03 |
| Treatment of Classic Mid-trimester PPROM by Means of Continuous Amnioinfusion Continuous amnioinfusion with Amnion Flush Solution through the intraamniotic catheter - Bronchopulmonary Dysplasia, Necrotizing Enterocolitis | Phase 3 | Unknown | Martin-Luther-Universität Halle-Wittenberg | 68 | 2021-01-01 | 2021-01-12 |
Showing 20 of 92. Sign in to see all of them.
Bronchopulmonary Dysplasia (45) · Acute Lung Injury (32) · Respiratory Distress Syndrome (31) · Premature Birth (21) · Respiratory Insufficiency (8) · COVID-19 (7) · Lung Diseases (6) · Meconium Aspiration Syndrome (5) · Sepsis (5) · Respiratory Tract Diseases (4) · Ventilator-Induced Lung Injury (4) · Coronavirus Infections (3) · Dyspnea (3) · Leukomalacia, Periventricular (3)
Respiratory Tract Diseases (88) · Lung Diseases (86) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (52) · Infant, Newborn, Diseases (48) · Infant, Premature, Diseases (47) · Ventilator-Induced Lung Injury (44) · Respiration Disorders (37) · Female Urogenital Diseases and Pregnancy Complications (27) · Urogenital Diseases (27) · Pregnancy Complications (26) · Obstetric Labor Complications (21) · Obstetric Labor, Premature (21) · Pathological Conditions, Signs and Symptoms (20) · Infections (18)
Sodium Chloride (7) · Saline Solution (6) · Budesonide (4) · Endothelium-Dependent Relaxing Factors (4) · Hydrocortisone (3) · Methylprednisolone (3) · Nitric Oxide (3) · Standard of Care (3) · Surface-Active Agents (3) · aviptadil (3) · Azithromycin (2) · Continuous Positive Airway Pressure (2) · Dexamethasone (2) · Oxygen (2) · Palivizumab (2)
NICHD Neonatal Research Network (8) · National Heart, Lung, and Blood Institute (NHLBI) (7) · APR Applied Pharma Research s.a. (3) · Assistance Publique - Hôpitaux de Paris (2) · Guangdong Women and Children Hospital (2) · Mallinckrodt (2) · McMaster University (2) · Roberta Ballard (2) · The University of Texas Health Science Center, Houston (2) · University of Alabama at Birmingham (2) · University of Colorado, Denver (2) · AO GENERIUM (1) · AbbVie (1) · Abbott (1) · Abbott Nutrition (1)
United States (43) · Canada (12) · France (11) · China (8) · Belgium (6) · Germany (6) · Italy (6) · United Kingdom (6) · Netherlands (5) · Spain (5) · Austria (3) · Israel (3) · Russia (3) · Sweden (3) · Australia (2)
Seetha Shankaran, MD (7) · Avroy A. Fanaroff, MD (5) · Barbara J. Stoll, MD (5) · Edward F. Donovan, MD (5) · Richard A. Ehrenkranz, MD (5) · Sheldon B. Korones, MD (5) · Charles R. Bauer, MD (4) · David K. Stevenson, MD (4) · Lu-Ann Papile, MD (4) · James A. Lemons, MD (3) · Jon E. Tyson, MD MPH (3) · Jonathan C Javitt, MD, MPH (3) · Waldemar A. Carlo, MD (3) · William Oh, MD (3) · Aaron Chiu, MD (2)
PMID 27440140, PMID 22307571, PMID 10400143, PMID 10545589, PMID 10802492, PMID 11150359, PMID 11416871, PMID 12219057, PMID 14510322, PMID 14993550, PMID 15767942, PMID 16014597, PMID 16651303, PMID 16870913, PMID 16870914, PMID 16939737, PMID 17307536, PMID 17426195, PMID 18245420, PMID 19117884, PMID 19713451, PMID 19841125, PMID 19841128, PMID 20138299, PMID 20405117, PMID 20472937, PMID 20472939, PMID 20587676, PMID 20591191, PMID 20633284, PMID 21562125, PMID 21976613, PMID 22059409, PMID 22120766, PMID 22371462, PMID 22738947, PMID 22943074, PMID 23268664, PMID 23339639, PMID 23944299, PMID 24289974, PMID 24335442, PMID 24388320, PMID 24725582, PMID 24835849, PMID 24876196, PMID 24996573, PMID 25425651, PMID 25554820, PMID 25647203
U10HD021373 (7), U10HD021385 (7), U10HD027853 (7), U10HD027880 (7), U10HD021364 (6), U10HD021397 (6), U10HD027851 (6), U10HD027856 (6), U10HD027871 (6), U10HD027904 (6), M01RR000750 (5), M01RR008084 (5), U10HD021415 (5), U10HD027881 (5), U10HD034216 (5)